Earnings Per Share, Basic in USD/shares of Eiger BioPharmaceuticals, Inc. from Q1 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Eiger BioPharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and change rate from Q1 2020 to Q4 2023.
  • Eiger BioPharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending 31 Dec 2023 was -49.4 USD/shares, a 27.4% increase year-over-year.
  • Eiger BioPharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending 31 Dec 2023 was -51 USD/shares, a 27.2% increase year-over-year.
  • Eiger BioPharmaceuticals, Inc. annual Earnings Per Share, Basic for 2023 was -50.8 USD/shares, a 27.2% increase from 2022.
  • Eiger BioPharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was -69.7 USD/shares, a 6874% decline from 2021.
  • Eiger BioPharmaceuticals, Inc. annual Earnings Per Share, Basic for 2021 was -1 USD/shares, a 56.7% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

Eiger BioPharmaceuticals, Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 -$51 -$49 +$18.60 +27.4% 01 Oct 2023 31 Dec 2023 10-K 08 Apr 2024
Q3 2023 -$69 $0 +$0.21 +33.9% 01 Jul 2023 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 -$70 $0 +$0.04 +7.84% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 -$70 -$1 +$0.12 +18.8% 01 Jan 2023 31 Mar 2023 10-Q 11 May 2023
Q4 2022 -$70 -$68 -$67 -10520% 01 Oct 2022 31 Dec 2022 10-K 08 Apr 2024
Q3 2022 -$2 -$1 +$0.03 +4.62% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 -$2 -$1 +$0.06 +10.5% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 -$3 -$1 -$2 -174% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 -$1 -$1 01 Oct 2021 31 Dec 2021 10-K 17 Mar 2023
Q3 2021 -$1 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022
Q2 2021 -$1 +$0.03 +5% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022
Q1 2021 $0.86 +$1.48 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022
Q2 2020 -$1 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021
Q1 2020 -$1 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021

Eiger BioPharmaceuticals, Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$51 +$19.00 +27.2% 01 Jan 2023 31 Dec 2023 10-K 08 Apr 2024
2022 -$70 -$69 -6874% 01 Jan 2022 31 Dec 2022 10-K 08 Apr 2024
2021 -$1 +$1.31 +56.7% 01 Jan 2021 31 Dec 2021 10-K 17 Mar 2023
2020 -$2 01 Jan 2020 31 Dec 2020 10-K 17 Mar 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.